Home DatasetsExperiment Details
E-GEOD-23978 GSE23978 transcription profiling by array Mus musculus

Genomic Profiling of mouse mammary tumor models identifies miRNA signatures associated with mammary tumor lineage (primary tumors and normal mammary glands)

·Released July 20, 2011 ·Updated Aug. 16, 2011
46
Samples
46
Assays
1
Array Platforms
Description

MicroRNAs (miRNAs) are small, non-coding, endogenous RNAs involved in many human diseases including breast cancer. miRNA expression profiling of human breast cancers has identified miRNAs related to the clinical diversity of the disease and potentially provides novel diagnostic and prognostic tools for breast cancer therapy. In order to further understand the roles of miRNAs in association with oncogenic drivers and in specifying sub-types of breast cancer, we performed miRNAexpression profiling on mammary tumors from eight well-characterized genetically -engineered Mouse (GEM) models of human breast cancer including MMTV–H-Ras, -Her2/neu, -c-Myc, -PymT, –Wnt1 and C3(1)/SV40 T/t-antigen transgenic mice, BRCA1fl/fl;p53+/-;MMTV-cre and the p53fl/fl ;MMTV-cre transplant model. miRNA expression data for 41 mouse primary mammary tumors and 5 mouse normal mammary glands

Array Platforms
A-GEOD-10880
LMT_mouse miRNA_v2 microarray(46 items)
Sample Attributes
Organism
Mus musculus
strain
129B6/FVB, BALB/c, FVB
Experiment Info
Accession
E-GEOD-23978
GEO ID
GSE23978
Type
transcription profiling by array
Organism
Mus musculus
Released
July 20, 2011
Updated
Aug. 16, 2011
Submitter
Jeffrey E Green、 Daniel Medina、 Yi Li、 Min Zhu、 Robert Stephen、 Chang H Kim、 Jeff Green、 Chuxia Deng、 Ming Yi
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]